SCHEMBL21136816

SCHEMBL21136816

CC(C)(C)OC(=O)N1CCN(c2c(N)cnc3c(F)c(Br)c(F)cc23)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.43
KCNH2 Q12809 2/20 0.42
MAP4K4 O95819 1/20 0.41
SMARCA2 P51531 1/20 0.41
SMARCA4 P51532 1/20 0.41
PBRM1 Q86U86 1/20 0.41
PIK3CA P42336 1/20 0.40
RET P07949 1/20 0.39
KIT P10721 2/20 0.39
PTPN11 Q06124 1/20 0.38
CKS1B P61024 2/20 0.38
SKP1 P63208 2/20 0.38
SKP2 Q13309 2/20 0.38
ALK Q9UM73 1/20 0.37
HTT P42858 1/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21136729 0.87 GPR119 (0.41) GPR119KCNH2MAP4K4KITCKS1B
SCHEMBL27094365 0.86 MAP4K4 (0.42) GPR119KCNH2MAP4K4SMARCA2SMARCA4
SCHEMBL16647196 0.81 KIT (0.52) GPR119KCNH2MAP4K4SMARCA2SMARCA4
SCHEMBL16636974 0.79 MAPK8 (0.39) GPR119KCNH2MAP4K4RETKIT
SCHEMBL16636900 0.78 MAPK8 (0.39) GPR119KCNH2RETKITPTPN11
SCHEMBL25333920 0.77 GBA1 (0.44) GPR119KCNH2MAP4K4KITCKS1B
SCHEMBL21136735 0.77 KCNH2 (0.47) GPR119KCNH2CKS1BSKP1SKP2
SCHEMBL20570346 0.77 NR1H2 (0.46) GPR119KCNH2RET
SCHEMBL21136722 0.76 MAP4K4 (0.42) GPR119KCNH2MAP4K4SMARCA2SMARCA4
SCHEMBL21136711 0.75 MAPK8 (0.41) GPR119KCNH2KITALKMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110751-A1 TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2019-06-13 WO disclosed